NM_000059.4(BRCA2):c.8702G>A (p.Gly2901Asp) AND Ovarian cancer
- Germline classification:
- no classifications from unflagged records (1 submission)
- Last evaluated:
- Oct 16, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003153312.10
Allele description [Variation Report for NM_000059.4(BRCA2):c.8702G>A (p.Gly2901Asp)]
NM_000059.4(BRCA2):c.8702G>A (p.Gly2901Asp)
Condition(s)
-
PREDICTED: Homo sapiens collagen type IV alpha 6 chain (COL4A6), transcript vari...
PREDICTED: Homo sapiens collagen type IV alpha 6 chain (COL4A6), transcript variant X7, mRNAgi|2217390992|ref|XM_047441816.1|Nucleotide
-
Control male biol rep 1 [AORF-1-1]
Control male biol rep 1 [AORF-1-1]biosample
-
SAMN30648351 (1)
SRA
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Flagged submissions
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV003843612 | Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University | flagged submission Reason: Outlier claim with insufficient supporting evidence Notes: None (ACMG Guidelines, 2015) | Likely pathogenic (Jan 1, 2022) | germline | clinical testing |
Last Updated: Nov 3, 2024